Filing Details
- Accession Number:
- 0001562180-16-001471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-03 09:27:07
- Reporting Period:
- 2016-02-01
- Filing Date:
- 2016-02-03
- Accepted Time:
- 2016-02-03 09:27:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557883 | Dermira Inc. | DERM | Pharmaceutical Preparations (2834) | 273267680 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208907 | G Thomas Wiggans | C/O Dermira, Inc., 275 Middlefield Road, Suite 150 Menlo Park CA 94025 | Ceo & Chairman Of The Board | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-02-01 | 8,700 | $27.23 | 238,480 | No | 4 | S | Indirect | By the Wiggans Living Trust dated 5/14/02 |
| Common Stock | Disposition | 2016-02-01 | 300 | $27.89 | 238,180 | No | 4 | S | Indirect | By the Wiggans Living Trust dated 5/14/02 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By the Wiggans Living Trust dated 5/14/02 |
| No | 4 | S | Indirect | By the Wiggans Living Trust dated 5/14/02 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,620 | Indirect | By the Amanda Wiggans Irrevocable Gifting Trust dated 2/24/11 |
| Common Stock | 8,620 | Indirect | By the Elizabeth Wiggans Irrevocable Gifting Trust dated 2/24/11 |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $26.77 to $27.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The Reporting Person is a Co-Trustee.
- This transaction was executed in multiple trades at prices ranging from $27.78 to $27.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The Reporting Person has no voting or dispositive power over the shares held by the trust.
Billionaire Hedge Funds
